Some recently developed tau PET tracers, such as [18F]PI-2620, have also been shown to bind to 4R tauopathies, such as PSP or corticobasal degeneration (CBD), showing promising results for the diagnosis of other non-AD tau pathologies [15, 23, 24]. Here, MAPT is linked to Alzheimer disease.